Vasopressin for refractory hypotension during cardiopulmonary bypass

West Indian Medical Journal

Volumn 56, Issue 6, 2007, Pages 550-554

  McGaw, C ^a   Scarlett, M ^a   Irvine, R ^a   Ramphal, P ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DALTEPARIN; DIGOXIN; DOPAMINE; FENTANYL; FUROSEMIDE; GELATIN; HEPARIN; ISOFLURANE; LISINOPRIL; MIDAZOLAM; MILRINONE; NITRATE; NITRIC OXIDE; NORADRENALIN; OXYGEN; PANCURONIUM; PHENYLEPHRINE; POTASSIUM CHLORIDE; SPIRONOLACTONE; VASOPRESSIN;

ACUTE HEART INFARCTION; ACUTE KIDNEY TUBULE NECROSIS; AGED; ANGIOCARDIOGRAPHY; ANURIA; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDOTRACHEAL INTUBATION; ERYTHROCYTE TRANSFUSION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPOKINESIA; HYPOTENSION; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; PLEURA EFFUSION; PLEURODESIS; RESPIRATORY DISTRESS; THORAX RADIOGRAPHY;

AGED; CARDIOPULMONARY BYPASS; HUMANS; HYPOTENSION; INTRAOPERATIVE COMPLICATIONS; MALE; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 42349088166     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gordon RJ, Ravin M, Rawitscher RE, Daicoff GR. Changes in arterial pressure, viscosity and resistance during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1975; 69: 552-61.
2. Gordon RJ, Ravin M, Daicoff GR, Rawitscher RE. Effects of hemodilution on hypotension during cardiopulmonary bypass. Anesth Analg 1975; 54: 482-8.
3. Talbot MP, Tremblay I, Denault AY, Belisle S. Vasoprcssin for refractory hypotension during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2000; 120: 401-2.
4. Pappalardo F. Landoni G, Franco A, Monaco C, Marino G. Torri G. Prolonged refractory hypotension in cardiac surgery after institution of cardiopulmonary bypass. J Cardithorac Vasc Anesth 2002; 16: 477-9.
5. Argenziano M, Choudhri AF, Oz MC, Rose EA, Smith CR, Landry DW. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96 (9 Suppi 11): II-286-90.
6. Argenziano M. Chen JM. Choudri AF, Cullinane S, Garfein E, Weinberg AD et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of novel pressor agent. J Thorac Cardiovasc Surg 1998; 116: 973-80.
7. Branthwaite MA. Prevention of neurological damage during open-heart surgery. Thorax 1975; 30: 258-61.
8. Gomes WJ. Carvalho AC. Palma JH. Goncalves I Jr, Buffolo E. Vasoplegic syndrome: a new dilemma. Journal of Thorac and Cardiovasc Surg 1994; 104: 942-3.
9. Landry DW. Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-95.
10. Dunser MW, Mayr AJ, Ulmer H, Ritsch N. Knotzer H, Werner R et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and post-cardiotomy shock: A retrospective analysis. Anesth Analg 2001; 93: 7-13.
11. Tsuneyoshi I. Yamada H. Kakihana Y, Nakamura M, Nakano Y. Boyle WA 3rd. Hemodynamics and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29: 487-9.
12. Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med 2004; 30: 1276-91.
13. Morales D. Madigan J, Cullinane S, Chen J, Heath M, Oz MC. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999; 100: 226-9.
14. Luckner G, Dunser MW. Jochberger S, Mayr VD, Wenzel V, Ulmer H et al Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005; 33: 2659-66.
15. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25: 1279-82.
16. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Allessandro et al. Vasoprcssin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95: 1122-5.
17. Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumarm G, Pajk W et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003; 107: 2313-9.
18. Dunser MW, Wenzel V, Mayr AJ, Hasibeder WR Management of vasodilatory shock: Defining the role of arginine vasopressin. Drugs 2003; 63: 237-56.
19. Mekontso-Dessap A, Houel R, Soustelle C, Kirsch M, Thebert D, Loisance DY Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 2001; 71: 1428-32.
20. Cohen RD, Woods HE Clinical and Biochemical Aspects of Lactic Acidosis. Boston: Blackwell Scientific Publications, 1976.
21. Cremer J, Martin M, Redt H, Bahrami S, Abraham C, Graeter T et al. Systemic inflammatory response after cardiac operations. Ann Thorac Surg 1996; 61: 1714-20.
22. Bakker J, Coffernils M, Leon M, Gris P, Vincent JL. Blood lactate, levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 1991; 99: 956-62.
23. Vincent JL, Dufaye P, Berré J, Leeman M, Degaute JR Kahn RJ. Serial lactate determinations during circulatory shock. Crit Care Med 1983; 11: 449-51.
24. Goff JS. Gastroesophageal varices: pathogenesis and therapy of acute bleeding. Gastroenterol Clin North Am 1993; 22: 779-800.
25. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A. High dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003; 31: 2646-50.